CVS Health Corporation (LON:0HRS)
London · Delayed Price · Currency is GBP · Price in USD | Market Cap | 73.77B |
| Revenue (ttm) | 291.39B |
| Net Income (ttm) | 348.91M |
| Shares Out | n/a |
| EPS (ttm) | 0.28 |
| PE Ratio | 211.43 |
| Forward PE | 11.23 |
| Dividend | 2.03 (2.58%) |
| Ex-Dividend Date | Oct 23, 2025 |
| Volume | 2,065 |
| Average Volume | 4,579 |
| Open | 77.60 |
| Previous Close | 77.87 |
| Day's Range | 76.90 - 78.82 |
| 52-Week Range | 43.56 - 85.80 |
| Beta | 0.48 |
| RSI | 50.77 |
| Earnings Date | Feb 4, 2026 |
About CVS Health
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPs and Medicaid health care management services. It serves employer groups, individuals, coll... [Read more]
Financial Performance
In 2024, CVS Health's revenue was $370.66 billion, an increase of 3.93% compared to the previous year's $356.62 billion. Earnings were $4.61 billion, a decrease of -44.70%.
Financial numbers in USD Financial StatementsNews
CVS Stock Gains From Offering MMR Vaccine to South Carolina Residents
CVS Health shares jump after the company begins offering MMR vaccines across South Carolina pharmacies and clinics post a measles outbreak.
Gabelli Pet Parents' Fund Q3 2025 Contributors And Detractors
Chewy Inc. gained 12% during the quarter as the company delivered solid results driven by higher autoship subscription activity and expanding private-label offerings. The largest contributors to Fund ...
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...
SA Asks: Are health insurance stocks a buy, sell, or hold right now?
Are health insurance stocks like UnitedHealth, CVS, and Oscar a buy, sell, or hold right now? Seeking Alpha analysts weigh in. Read more here.
CVS Health (CVS) Adjusts 2026 Revenue Outlook
CVS Health (CVS) Adjusts 2026 Revenue Outlook
Notable healthcare headlines for the week: CVS, Eli Lilly and Novartis in focus
Top Wall Street analysts are upbeat on these 3 dividend stocks for enhanced returns
TipRanks' ranking service discusses three dividend-paying stocks, including Devon Energy and CVS Health.
Why CVS Health (CVS) is a Top Momentum Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
CVS: Bernstein Raises Price Target for CVS Health to $87 | CVS Stock News
CVS: Bernstein Raises Price Target for CVS Health to $87 | CVS Stock News
The consumer is frustrated right now, says CVS Health CEO David Joyner
CNBC's Jim Cramer sits down with CVS Health CEO David Joyner to discuss the company's investor day, how healthcare technology is changing, the role of artificial intelligence and more.
Guru Fundamental Report for CVS
Below is Validea's guru fundamental report for CVS HEALTH CORP (CVS). Of the 22 guru strategies we follow, CVS rates highest using our Multi-Factor Investor model based on the published strategy of Pi...
CVS Health offering measles vaccine to South Carolina residents amid the state's current outbreak
Unvaccinated residents can receive a measles vaccine at select CVS Pharmacy and MinuteClinic locations across the state WOONSOCKET, R.I. , Dec. 11, 2025 /PRNewswire/ -- As South Carolina public health...
CVS Health (CVS) Receives Analyst Price Target Upgrade to $98 | CVS Stock News
CVS Health (CVS) Receives Analyst Price Target Upgrade to $98 | CVS Stock News
CVS Health (CVS) Sees Analyst Rating Update from Piper Sandler | CVS Stock News
CVS Health (CVS) Sees Analyst Rating Update from Piper Sandler | CVS Stock News
CVS Health Is Seeing Margin And App Momentum, Analyst Highlights
On Tuesday, CVS Health Inc . (NYSE: CVS) projected 2025 revenue of at least $400 billion versus the consensus of $394.59 billion, with operating income of $4.37 billion to $4.54 billion. The drug ret...
CVS Health Corporation (CVS) Analyst/Investor Day Prepared Remarks Transcript
CVS Health Corporation (CVS) Analyst/Investor Day December 9, 2025 8:00 AM ESTCompany ParticipantsLarry McGrath - Executive VP, Chief Strategy Officer &...
CVS Health (CVS) Analysts Maintain Overweight, Raise Price Target | CVS Stock News
CVS Health (CVS) Analysts Maintain Overweight, Raise Price Target | CVS Stock News
Cramer's Stop Trading: CVS Health
CNBC's Jim Cramer explains why he is keeping an eye on shares of CVS Health.
Cramer’s Stop Trading: CVS Health
CNBC’s Jim Cramer explains why he is keeping an eye on shares of CVS Health.
Mizuho Raises Price Target for CVS Health (CVS) to $95.00 | CVS Stock News
Mizuho Raises Price Target for CVS Health (CVS) to $95.00 | CVS Stock News
CVS Health (CVS) Receives Price Target Increase from Morgan Stanley | CVS Stock News
CVS Health (CVS) Receives Price Target Increase from Morgan Stanley | CVS Stock News
Buy Or Fear CVS Stock At $78?
CVS Health's (NYSE: CVS) latest results affirm several points: their sales and adjusted profits remain stable, and they are adjusting their forecasts upward. Nonetheless, the quality of their profits ...
CVS (CVS) Analyst Rating Update: Baird Raises Price Target to $92 | CVS Stock News
CVS (CVS) Analyst Rating Update: Baird Raises Price Target to $92 | CVS Stock News
CVS Health Corporation (CVS) Analyst/Investor Day - Slideshow
The consumer is frustrated right now, says CVS Health CEO David Joyner
CNBC’s Jim Cramer sits down with CVS Health CEO David Joyner to discuss the company's investor day, how healthcare technology is changing, the role of artificial intelligence and more.